Sign in

CIK 0001159036 · Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880488686
Phone
(858) 794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,884,955
in 5 filings, $19.9M under 10b5-1 plans

Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-05 Lang James Paul Director Grant or award · Option to Purchase Common Stock +6,040 6,040
2026-05-05 Henderson Jeffrey William Director Grant or award +3,796 36,572
2026-05-05 Henderson Jeffrey William Director Grant or award · Option to Purchase Common Stock +6,040 6,040
2026-05-05 DUNCAN BARBARA GAYLE Director Grant or award +3,796 23,715
2026-05-05 DUNCAN BARBARA GAYLE Director Grant or award · Option to Purchase Common Stock +6,040 6,040
2026-05-05 Connaughton Bernadette Director Grant or award +6,796 45,294
2026-05-05 Connaughton Bernadette Director Grant or award · Option to Purchase Common Stock +6,040 6,040
2026-05-01 Connaughton Bernadette Director Sale 10b5-1 −1,625 $63.48 $103K 38,498
2026-04-06 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +10,000 $12.07 $121K 777,780
2026-04-06 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −5,900 $63.14 $373K 771,880
2026-04-06 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −4,100 $64.02 $262K 767,780
2026-04-06 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −10,000 $12.07 $121K 101,923
2026-04-02 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $12.07 $241K 787,780
2026-04-02 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −15,800 $64.06 $1.0M 771,980
2026-04-02 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −4,200 $64.89 $273K 767,780
2026-04-02 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $12.07 $241K 111,923
2026-04-01 RAMSAY DAVID A Interim CFO Grant or award · Restricted Stock Units +10,000 10,000
2026-04-01 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $12.07 $241K 787,780
2026-04-01 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −19,000 $65.36 $1.2M 768,780
2026-04-01 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −1,000 $65.71 $66K 767,780

Page 7 of 26 · 513 trades